Thorkil Kastberg Christensen

Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark.

Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.

Jørgen Kruuse A/S manufactures and supplies veterinary products needed in the treatment and care of animals with worldwide distribution. Its brands include KRUUSE, BUSTER, KRUTEX, VALUELINE, EQUIVET and BOVIVET. The company was founded in 1939 and is headquartered in Langeskov, Denmark.

Part of Novo Nordisk Fonden, Novo Nordisk China is a Chinese global biopharmaceutical company headquartered in Copenhagen, Denmark. The company is based in Beijing, China. The company's goal is to drive change in order to overcome serious chronic diseases such as diabetes, obesity, rare blood diseases, and endocrine disorders.

Danish-Chinese Business Forum is an executive networking platform that aims to improve business relations between Denmark and China. The non-profit company is based in Copenhagen, Denmark. Additionally, the provided dictionary includes information about two other companies. The first is a family-owned Danish Pharmaceutical Industry that specializes in providing quality food supplements with natural vitamins and organic minerals. The second is Royal Arctic Line, which offers ocean and coastal liner services to, from, and within Greenland, as well as port operations and warehouse management in 13 ports.

BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN.